Unique ID issued by UMIN | UMIN000010411 |
---|---|
Receipt number | R000012176 |
Scientific Title | A randomized controlled trial to compare empiric antifungal therapy and D-index-guided early therapy during neutropenia. (CEDMIC trial) |
Date of disclosure of the study information | 2013/05/01 |
Last modified on | 2018/02/20 10:29:18 |
A randomized controlled trial to compare empiric antifungal therapy and D-index-guided early therapy during neutropenia. (CEDMIC trial)
RCT to compare empiric antifungal therapy and D-index-guided early therapy (CEDMIC trial)
A randomized controlled trial to compare empiric antifungal therapy and D-index-guided early therapy during neutropenia. (CEDMIC trial)
RCT to compare empiric antifungal therapy and D-index-guided early therapy (CEDMIC trial)
Japan |
Hematological malignancies(acute leukemia, myelodysplastic syndrome, lymphoma, myeloma, and so on)
Hematology and clinical oncology |
Malignancy
NO
To test the non-inferiority of D-index-guided early antifungal therapy compared to empiric therapy during neutropenia.
Safety,Efficacy
Confirmatory
Phase III
Proven/Probable invasive fungal infection
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
2
Treatment
Medicine |
D-index-guided early antifungal therapy
Empiric antifungal therapy
16 | years-old | <= |
79 | years-old | >= |
Male and Female
1)Patients with hematological malignancies who undergo chemotherapy or stem cell transplantation
2)Aged between 16 and 79 years
3)Expected duration of neutropenia at least 7 days
4)No grade III-IV renal or liver dysfunction
5)ECOG-PS 0-2
6)Written informed consent obtained
1)Previous history of invasive fungal infection
2)Receiving antifungal agents other than prophylactic administration
3)Suspected active infection
4)Planned to receive antifungal prophylaxis with polyenes or candins
5)Allergic reaction to candins
6)Pregnant or possibly pregnant
7)HIV positive
8)Not suitable for thie trial judged by attending physicians
420
1st name | |
Middle name | |
Last name | Yoshinobu Kanda |
Saitama Medical Center, Jichi Medical University
Division of Hematology
Amanuma 1-847, Omiya, Saitama, Japan
048-647-2111
ycanda-tky@umin.ac.jp
1st name | |
Middle name | |
Last name | Yoshinobu Kanda |
Japan Febrile Neutropenia Study Group
Japan Febrile Neutropenia Study Group
Jonan, Fukuoka-city
092-801-2845
http://www.fnkenkyu.com/index.html
ycanda-tky@umin.ac.jp
Japan Febrile Neutropenia Study Group
Astellas
Profit organization
NO
2013 | Year | 05 | Month | 01 | Day |
http://www.fnkenkyu.com/index.html
Unpublished
Not fixed
Completed
2013 | Year | 03 | Month | 01 | Day |
2013 | Year | 05 | Month | 01 | Day |
2017 | Year | 12 | Month | 31 | Day |
2018 | Year | 12 | Month | 31 | Day |
2013 | Year | 04 | Month | 03 | Day |
2018 | Year | 02 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012176
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |